Northwire Canada EditionSaturday, October 17, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 81
  1. Dec 23, 2025 · 17:20 · LSL

    LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING

    LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING

    01
  2. Dec 23, 2025 · 16:41 · TLT

    Theralase(R) Closes $1.3 M Non-Brokered Private Placement

    Theralase(R) Closes $1.3 M Non-Brokered Private Placement

    02
  3. Dec 23, 2025 · 16:19 · PRN

    Profound closes $36-million offering

    Profound closes $36-million offering

    03
  4. Dec 23, 2025 · 16:04 · QNTM

    Quantum Biopharma completes dosing in Lucid-MS studies

    Quantum Biopharma completes dosing in Lucid-MS studies

    04
  5. Dec 23, 2025 · 16:01 · AGN

    Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

    Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche

    05
  6. Dec 23, 2025 · 13:21 · SEGN

    NEW CHIEF EXECUTIVE OFFICER INVESTORS UPDATE

    NEW CHIEF EXECUTIVE OFFICER INVESTORS UPDATE

    06
  7. Dec 23, 2025 · 09:11 · LSL

    LSL PHARMA GROUP CLOSES $10M OF UPSIZED $12M BROKERED OFFERING AND ENTERS INTO DEFINITIVE AGREEMENT FOR THE ACQUISITION OF JUNO OTC

    LSL PHARMA GROUP CLOSES $10M OF UPSIZED $12M BROKERED OFFERING AND ENTERS INTO DEFINITIVE AGREEMENT FOR THE ACQUISITION OF JUNO OTC

    07
  8. Dec 23, 2025 · 08:00 · QNTM

    Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

    Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

    08
  9. Dec 23, 2025 · 08:00 · PRN

    Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

    Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

    09
  10. Dec 22, 2025 · 09:31 · ENBI

    Entheon Announces Letter of Intent with Nutravisor Inc.

    Entheon Announces Letter of Intent with Nutravisor Inc.

    10
  11. Dec 22, 2025 · 09:00 · QNTM

    World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

    World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

    11
  12. Dec 19, 2025 · 19:16 · APS

    Aptose Biosciences to reschedule special meeting

    Aptose Biosciences to reschedule special meeting

    12
  13. Dec 19, 2025 · 17:06 · SHRX

    Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options

    Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options

    13
  14. Dec 19, 2025 · 16:23 · PRN

    Profound arranges $40-million financing

    Profound arranges $40-million financing

    14
← Newer Older →